Azathioprine Discontinuation linked to CC genotype and hematopoietic toxicity |
Clinical News
eMediNexus Coverage from: 
Azathioprine Discontinuation linked to CC genotype and hematopoietic toxicity

0 Read Comments                

Annals of Internal Medicine reported a study which stated that patients with inflammatory diseases who have the CC genotype are more likely to stop taking azathioprine (Imuran) due to hematological toxicity and require dose reductions for thiopurine dosages.Azathioprine is a thiopurine immunosuppressant medication that is used to prevent kidney transplant rejection and active rheumatoid arthritis. Irritable bowel disease (IBD), systemic lupus erythematosus (SLE), and other disorders can be treat...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now